LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Vaccination of healthcare workers against influenza: does a day off make a difference?

    Maltezou, H C / Christophilea, O / Tedoma, A / Katerelos, P / Dounias, G

    The Journal of hospital infection

    2018  Volume 99, Issue 2, Page(s) 181–184

    Abstract: This article presents the results of actions undertaken to increase influenza vaccine uptake by healthcare workers (HCWs) in Greece during the 2016-2017 influenza season. Influenza vaccination among HCWs increased from 10.9% in acute care hospitals and ... ...

    Abstract This article presents the results of actions undertaken to increase influenza vaccine uptake by healthcare workers (HCWs) in Greece during the 2016-2017 influenza season. Influenza vaccination among HCWs increased from 10.9% in acute care hospitals and 24.3% in primary healthcare centres in 2015-2016 to 18% in acute care hospitals and 34.6% in primary healthcare centers in 2016-2017. Vaccination on site at the healthcare facility and use of reward systems were significantly associated with increased vaccination rates. Offering vaccinated HCWs one day off work was associated with the greatest increase in influenza vaccine uptake.
    MeSH term(s) Cross Infection/prevention & control ; Greece ; Health Personnel ; Humans ; Influenza, Human/prevention & control ; Motivation ; Vaccination Coverage
    Language English
    Publishing date 2018-03-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 779366-2
    ISSN 1532-2939 ; 0195-6701
    ISSN (online) 1532-2939
    ISSN 0195-6701
    DOI 10.1016/j.jhin.2018.01.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vaccinations and Malaria Chemoprophylaxis of Adolescents Traveling From Greece to International Destinations: A Nine-Year Prospective Study.

    Maltezou, Helena C / Pavli, Androula / Theodoridou, Kalliopi / Katerelos, Panos / Spilioti, Athina / Tedoma, Anastasia / Lymperi, Ioanna / Theodoridou, Maria

    The Pediatric infectious disease journal

    2017  Volume 37, Issue 5, Page(s) e132–e135

    Abstract: Background: There are few publications focusing on vaccination and malaria chemoprophylaxis in adolescent travelers. We assessed pretravel vaccinations and malaria chemoprophylaxis of adolescents 12-18 years old traveling from Greece to international ... ...

    Abstract Background: There are few publications focusing on vaccination and malaria chemoprophylaxis in adolescent travelers. We assessed pretravel vaccinations and malaria chemoprophylaxis of adolescents 12-18 years old traveling from Greece to international destinations.
    Methods: We prospectively studied 239 adolescents 12-18 years old during 2008-2016. A standard questionnaire was used to collect data.
    Results: Adolescents sought pretravel services at a mean of 24.1 days before departure. Their main destinations were sub-Saharan Africa (79 adolescents; 33.1%), Latin America (56; 23.5%) and North America (26; 10.9%). Almost half (46.1%) of them planned to stay abroad for at least 3 months. Sixteen (7.4%) adolescents planned to visit friends and relatives. The yellow fever vaccine and the typhoid vaccine were the most frequently administered vaccines (74.1% and 20.5%, respectively), while the hepatitis A vaccine and the tetanus-diphtheria vaccine accounted for most routine vaccinations (18% and 14.2%, respectively). The rabies and the typhoid fever vaccines were administered inadequately to adolescents traveling to endemic areas. Malaria chemoprophylaxis should have been prescribed in many cases traveling to sub-Saharan Africa and the Indian subcontinent.
    Conclusions: Only a small number of adolescents from Greece traveling abroad seek pretravel counseling. We found significant gaps in typhoid fever and rabies vaccinations of adolescents traveling to endemic areas. We also found gaps in prescription of malaria chemoprophylaxis for those traveling to high-risk areas. There is a need to develop communication strategies to access adolescent travelers and improve appropriate vaccination and use of malaria chemoprophylaxis.
    MeSH term(s) Adolescent ; Africa South of the Sahara ; Antimalarials/therapeutic use ; Chemoprevention ; Child ; Female ; Greece ; Health Knowledge, Attitudes, Practice ; Humans ; Malaria/prevention & control ; Male ; North America ; Prospective Studies ; Rabies Vaccines/administration & dosage ; Surveys and Questionnaires ; Travel ; Typhoid-Paratyphoid Vaccines/administration & dosage ; Vaccination/statistics & numerical data ; Yellow Fever Vaccine/administration & dosage
    Chemical Substances Antimalarials ; Rabies Vaccines ; Typhoid-Paratyphoid Vaccines ; Yellow Fever Vaccine
    Language English
    Publishing date 2017-09-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000001782
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.

    Maltezou, Helena C / Katerelos, Panagiotis / Mavrouli, Maria / Lourida, Athanasia / Routsias, John G / Spanakis, Nicholas / Maragos, Antonios / Tedoma, Anastasia / Bassiakos, Yiannis / Koratzanis, Georgios / Mantagos, Stephanos / Metallidis, Simeon / Katragkou, Aspasia / Nikolaidis, Pavlos / Roilides, Emmanuel / Theodoridou, Maria / Tsakris, Athanassios

    Vaccine

    2011  Volume 29, Issue 38, Page(s) 6664–6669

    Abstract: Knowledge of seroprevalence rates against 2009 pandemic H1N1 virus will assist vaccination recommendations and the preparation of the health-care system during subsequent years. This study was conducted in Greece during June-August 2010 to estimate the ... ...

    Abstract Knowledge of seroprevalence rates against 2009 pandemic H1N1 virus will assist vaccination recommendations and the preparation of the health-care system during subsequent years. This study was conducted in Greece during June-August 2010 to estimate the seroprevalence rate against pandemic H1N1 virus. Persons presenting in 29 health-care facilities across the country were studied. Seroprevalence was estimated employing a virus-free ELISA that specifically recognizes 2009 H1N1 virus antibodies in human sera. Sera collected from 2005 to April 2009 were also used to estimate pre-pandemic seroprevalence rates. A total of 954 persons were studied. The overall seroprevalence rate was 28.5% (95% confidence interval=25.6-31.3%). Age-specific rates were 34.2% in persons 0-4 years, 36.3% in persons 5-19 years, 25.0% in persons 20-39 years, 23.4% in persons 40-59 years, and 31.8% in persons ≥ 60 years. The highest rates were recorded in the Regions of Ionian Islands (67%) and Epirus (42.9%), while the lowest (8.4%) in the Region of Thessaly. Age-specific attack rates of infection during 2009-2010 were 28.8% in persons 0-4 years, 32.5% in persons 5-19 years, 14.3% in persons 20-39 years, 19.1% in persons 40-59 years, and 14.4% in persons ≥ 60 years. Multivariate analysis revealed that Region of residence and caring for children <5 years were associated with increased risk for seropositivity. Urbanity, personal and family characteristics, working in a health-care facility or in a school, history of pandemic H1N1 vaccination or history of influenza-like illness during 2009-2010 were not associated with increased risk for seropositivity.
    MeSH term(s) Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Antibodies, Viral/blood ; Child ; Child, Preschool ; Enzyme-Linked Immunosorbent Assay/methods ; Female ; Geography ; Greece/epidemiology ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/immunology ; Influenza, Human/epidemiology ; Influenza, Human/virology ; Male ; Middle Aged ; Seroepidemiologic Studies ; Young Adult
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2011-09-02
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2011.06.098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece

    Maltezou, Helena C. / Katerelos, Panagiotis / Mavrouli, Maria / Lourida, Athanasia / Routsias, John G. / Spanakis, Nicholas / Maragos, Antonios / Tedoma, Anastasia / Bassiakos, Yiannis / Koratzanis, Georgios / Mantagos, Stephanos / Metallidis, Simeon / Katragkou, Aspasia / Nikolaidis, Pavlos / Roilides, Emmanuel / Theodoridou, Maria / Tsakris, Athanassios

    Vaccine

    Volume v. 29,, Issue no. 3

    Abstract: Knowledge of seroprevalence rates against 2009 pandemic H1N1 virus will assist vaccination recommendations and the preparation of the health-care system during subsequent years. This study was conducted in Greece during June–August 2010 to estimate the ... ...

    Abstract Knowledge of seroprevalence rates against 2009 pandemic H1N1 virus will assist vaccination recommendations and the preparation of the health-care system during subsequent years. This study was conducted in Greece during June–August 2010 to estimate the seroprevalence rate against pandemic H1N1 virus. Persons presenting in 29 health-care facilities across the country were studied. Seroprevalence was estimated employing a virus-free ELISA that specifically recognizes 2009 H1N1 virus antibodies in human sera. Sera collected from 2005 to April 2009 were also used to estimate pre-pandemic seroprevalence rates. A total of 954 persons were studied. The overall seroprevalence rate was 28.5% (95% confidence interval=25.6–31.3%). Age-specific rates were 34.2% in persons 0–4 years, 36.3% in persons 5–19 years, 25.0% in persons 20–39 years, 23.4% in persons 40–59 years, and 31.8% in persons ≥60 years. The highest rates were recorded in the Regions of Ionian Islands (67%) and Epirus (42.9%), while the lowest (8.4%) in the Region of Thessaly. Age-specific attack rates of infection during 2009–2010 were 28.8% in persons 0–4 years, 32.5% in persons 5–19 years, 14.3% in persons 20–39 years, 19.1% in persons 40–59 years, and 14.4% in persons ≥60 years. Multivariate analysis revealed that Region of residence and caring for children <5 years were associated with increased risk for seropositivity. Urbanity, personal and family characteristics, working in a health-care facility or in a school, history of pandemic H1N1 vaccination or history of influenza-like illness during 2009–2010 were not associated with increased risk for seropositivity.
    Keywords vaccines ; antibodies ; children ; pandemic ; humans ; people ; vaccination ; enzyme-linked immunosorbent assay ; influenza ; risk ; multivariate analysis ; serological surveys ; Influenza A virus ; islands ; seroprevalence
    Language English
    Document type Article
    ISSN 0264-410X
    Database AGRIS - International Information System for the Agricultural Sciences and Technology

    More links

    Kategorien

To top